This research explores the role of glymphatic system dysfunction and mitochondrial issues in Alzheimer's disease, suggesting they may accelerate neurodegeneration.
Key Points
Integrated dysfunction in the glymphatic system and mitochondria contributes to the progression of Alzheimer's disease.
The interrelation of impaired neurotoxin clearance and disrupted energy metabolism creates a vicious cycle that worsens cognitive decline.
Glymphatic clearance plays a critical role in removing amyloid-beta, linking its dysfunction to neurodegeneration.
Understanding these combined pathological factors may lead to new therapeutic strategies targeting Alzheimer's disease.